Rethinking the Future of Telehealth Prescribing of Controlled Substances: ASAM Pushes Back on DEA’s Special Registration Proposal
As the federal government continues to shape the future of virtual healthcare, a major addiction treatment advocacy group is raising red flags about one...
Medicaid to Prioritize Behavioral Health in 2025: What to Expect
State Medicaid programs across the U.S. are making behavioral health a top priority in 2025, reflecting a growing recognition of the need for expanded...
Behavioral Health: A Top Priority for Governors and a Boost for Centene Corp.’s Medicaid Business
In recent months, state governors across the U.S. have been putting behavioral health at the forefront of their healthcare agendas. The increasing recognition of...
Navigating the Landscape: Behavioral Health M&A Trends 2023
Fears of a sluggish year in the behavioral health mergers and acquisitions (M&A) market in 2023 may have been overstated. While deal sizes have...
Understanding the Role of Medications for Opioid Use Disorder: Why Methadone Leads in Treatment Retention
Opioid use disorder (OUD) is one of the most pressing public health crises in the world today. The impact of opioid addiction is devastating,...
Private Equity in Behavioral Health: The Villain or the Hero?
Every good story has a villain, and in the eyes of the federal government, the current villain in the behavioral health treatment industry is...
